Peripheral Artery Disease
📧 Sign up to get email alerts when something new happens for Peripheral Artery Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-07-15Clinical Trial Update: PTA vs. Primary Stenting of SFA Using Self-Expandable Nitinol Stents [Phase 4]
A Phase 4 trial comparing angioplasty (PTA) versus primary stenting of the superficial femoral artery using self-expandable nitinol stents i…
-
FDA approval · 2008-06-27FDA Approved: CILOSTAZOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for cilostazol filed by Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS trial_result · 2008-06-27Clinical Trial Update: FIRE-PAD: Functional Improvement Through Revascularization of the Extremities for Peripheral Arterial Disease
The FIRE-PAD trial evaluating functional improvement through revascularization for peripheral artery disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2008-06-09Clinical Trial Update: Comparison of Prosthetic Femoropopliteal Bypass Versus Viabahn Endoprosthesis for Treatment of Symptomatic Femoral Artery Occlusive Disease [NA]
Completed clinical trial comparing prosthetic femoropopliteal bypass versus Viabahn endoprosthesis for symptomatic femoral artery occlusive …
-
CLINICAL_TRIALS trial_result · 2008-05-16Clinical Trial Update: Safety/Feasibility Study of HBOC-201 in Amputation at/Below Knee From Critical Lower Limb Ischemia [Phase 2]
Phase 2 safety/feasibility trial of HBOC-201 in below-knee amputation due to critical limb ischemia has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2008-05-09Clinical Trial Update: (Cost) Effectiveness Study of Exercise Therapy in Patients With Peripheral Arterial Disease [NA]
Update on a cost-effectiveness study of exercise therapy for patients with peripheral artery disease presenting intermittent claudication; c…
-
CLINICAL_TRIALS trial_result · 2008-04-28Clinical Trial Update: Exercise for Elderly Peripheral Revascularized Patients [NA]
This completed clinical trial, led by the National Institute on Aging, studied an exercise program in elderly patients who had undergone per…
-
FDA approval · 2008-03-10FDA Approved: CILOSTAZOL — Supplemental Application (Chartwell RX, LLC)
FDA approves Chartwell RX, LLC's supplemental application for cilostazol (generic) under ANDA077021, enabling market authorization for a gen…
-
FDA approval · 2008-03-10FDA Approved: CILOSTAZOL — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for cilostazol filed by Chartwell RX, LLC.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Potential Role of CMV in Restenosis Following Angioplasty, in Atherosclerosis, and in Endothelial Dysfunction
A completed NHLBI-supported clinical trial update examining whether cytomegalovirus infection plays a role in restenosis after angioplasty a…
-
CLINICAL_TRIALS trial_result · 2008-02-08Clinical Trial Update: AMS INSIGHT 1 Study - Bioabsorbable Metal Stent Investigation in Chronic Limb Ischemia Treatment [Phase 2]
Phase 2 AMS INSIGHT 1 trial evaluating a bioabsorbable metal stent for chronic limb ischemia in peripheral artery disease has completed.
-
CLINICAL_TRIALS trial_result · 2008-01-18Clinical Trial Update: A Non-Randomized Study of the NightHawk Peripheral Plaque Excision System During Plaque Excision of Peripheral Arterial Disease [Phase 2]
This document reports a terminated, non-randomized Phase 2 trial evaluating the NightHawk Peripheral Plaque Excision System for peripheral a…
-
CLINICAL_TRIALS trial_result · 2008-01-15Clinical Trial Update: Study of Alfimeprase to Rapidly Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery on Leg Arteries [Phase 3]
A Phase 3 clinical trial of Alfimeprase for rapidly dissolving leg blood clots (to reduce the need for leg-artery surgery) has been complete…
-
FDA approval · 2008-01-14FDA Approved: CLOPIDOGREL BISULFATE — Original Application (Dr.Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories Limited's clopidogrel bisulfate tablet under an Original Application (ANDA076273). The approval enable…
-
CLINICAL_TRIALS trial_result · 2008-01-11Clinical Trial Update: Study of HGF Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia [Phase 2]
A Phase 2 clinical trial of a hepatocyte growth factor (HGF) plasmid vector to improve perfusion in critical limb ischemia has completed.
-
CLINICAL_TRIALS research · 2007-12-03Clinical Trial Update: The Burden of Peripheral Artery Occlusion Disease and Associated Factors in Peritoneal Dialysis Patients
This clinical trial update assesses the burden of peripheral artery disease in peritoneal dialysis patients and identifies associated factor…
-
CLINICAL_TRIALS trial_result · 2007-12-03Clinical Trial Update: Remote Endarterectomy Versus Suprageniculate Femoropopliteal Bypass [NA]
A clinical trial comparing remote endarterectomy to suprageniculate femoropopliteal bypass for peripheral artery disease is noted, with the …
-
CLINICAL_TRIALS trial_result · 2007-11-28Clinical Trial Update: Pilot Study to Evaluate the Safety and Preliminary Efficacy of the Peritec Peritoneal Lined Stent and Delivery System [EARLY_Phase 1]
An early-phase pilot trial update evaluating the safety and preliminary efficacy of the Peritec Peritoneal Lined Stent and Delivery System f…
-
CLINICAL_TRIALS trial_result · 2007-11-22Clinical Trial Update: Trial of VLTS-934 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial Disease [Phase 2]
This update notes the completion of a Phase 2 trial evaluating VLTS-934 for intermittent claudication due to peripheral artery disease.
-
FDA approval · 2007-09-20FDA Approved: PLAVIX — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approves a supplemental application for PLAVIX (clopidogrel) from Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2007-08-31Clinical Trial Update: Dacron vs Dardik for Fem-Pop Bypass [Phase 3]
Phase 3 trial comparing Dacron and Dardik vascular grafts for femoropopliteal bypass has completed.
-
FDA approval · 2007-08-16FDA Approved: CILOSTAZOL — Supplemental Application (Apotex Corp.)
FDA approves a supplemental application for cilostazol submitted by Apotex Corp.
-
CLINICAL_TRIALS trial_result · 2007-03-07Clinical Trial Update: Prostaglandin E1 (Liprostin) Treatment With Lower Limb Angioplasty for Peripheral Arterial Occlusive Disease [Phase 2]
Phase 2 trial evaluating prostaglandin E1 (Liprostin) in combination with lower limb angioplasty for peripheral arterial occlusive disease.
-
CLINICAL_TRIALS trial_result · 2007-02-21Clinical Trial Update: Balloon Angioplasty vs. Cutting Balloon Angioplasty of Femoropopliteal Arteries- a Randomized Controlled Trial [Phase 4]
Phase 4 randomized trial comparing Balloon Angioplasty to Cutting Balloon Angioplasty in the femoropopliteal arteries was terminated.
-
FDA approval · 2006-12-07FDA Approved: CILOSTAZOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Cilostazol submitted by Teva Pharmaceuticals USA, Inc., related to the approved Cilostazol p…